Two cancer stem cell‐targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model
Abstract A key implication of the cancer stem cell model is that for a cancer therapy to be curative, it is imperative to eliminate the cancer stem cells (CSCs) that drive tumor progression. The California Institute for Regenerative Medicine is supporting two novel approaches that target CSCs, one a...
Main Author: | Ingrid W. Caras |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.19-0424 |
Similar Items
-
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
by: Andres Garcia-Sampedro, et al.
Published: (2021-02-01) -
Differences and similarities between cancer and somatic stem cells: therapeutic implications
by: Fiorella Rossi, et al.
Published: (2020-11-01) -
Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications
by: Moses Fung, et al.
Published: (2017-05-01) -
Clinical development of targeted and immune based anti-cancer therapies
by: N. A. Seebacher, et al.
Published: (2019-04-01) -
Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials
by: Serena Silvestro, et al.
Published: (2020-01-01)